RESEARCH-USE BIOSIMILAR ANTIBODY

Elipovimab

Monoclonal antibody · IgG1

HIV-1 gp120IgG1RUO

Elipovimab is a potent broadly neutralizing HIV-1 antibody for the targeted elimination of HIV-infected cells

TARGETHIV-1 gp120
YMonoclonal antibody
CATALOGSC-BS-589
CATALOG NUMBERSC-BS-589
MOLECULAR WEIGHTApprox. 146.72 kDa
PRODUCT FORMATMonoclonal antibody

A research-use configuration for comparative antibody studies

Elipovimab is a potent broadly neutralizing HIV-1 antibody for the targeted elimination of HIV-infected cells

Elipovimab is a recombinant research-use antibody directed against HIV-1 gp120.

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte
Elipovimab | StellaCyte